PCSA Processa Pharmaceuticals, Inc.
$2.43
Processa Pharmaceuticals, Inc. (PCSA) is expected to report earnings on November 13, 2026, after the market close.
Processa Pharmaceuticals Reported Earnings
Earnings Date
Nov 13
Friday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$2.15
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.
Sector
Healthcare
Industry
Biotechnology